Nabsys Competitors and Similar CompaniesClear all
Denali Therapeutics's competitors and similar companies include Astellas Gene Therapies.
 Astellas Gene Therapies Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 2013 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations South San Francisco, US HQ Zürich, CH London, GB | Locations San Francisco, US HQ |
Employees | Employees 4225% decrease | Employees 4061% decrease |
Financial | ||
Net income | Net income ($512.5m) (FY, 2025) | Net income ($128.8m) (FY, 2018) |
Funding | ||
Total funding raised | Total funding raised $ 424.4m | Total funding raised $ 180m |
For sources of this data, please see the company profile
View Company Profiles
Astellas Gene Therapies
HQ
San Francisco, US
Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
View company